A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer
Status:
Completed
Trial end date:
2019-08-29
Target enrollment:
Participant gender:
Summary
The purpose of the phase 2, GT-201 clinical study is to determine if GC4419 administered
prior to intensity-modulated radiation therapy (IMRT) reduces the incidence, duration, and
severity of radiation induced oral mucositis in patients who have been diagnosed with locally
advanced, non-metastatic squamous cell carcinoma of the head and neck.